Modulators of the integrated stress pathway
Patent Information
- Application Number
- JP2023526483
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-10-18
- Filing Date
- 2021-10-29
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2041-10-29
Smart Images

Figure 2022094244000001 
Figure 2022094244000002 
Figure 2022094244000003
Abstract
Claims
1. Formula (I): or a pharma- ceutically acceptable salt thereof, During the ceremony, D is a bridged bicyclic cycloalkyl, a bridged bicyclic heterocyclyl, a 4- to 6-membered monocyclic cycloalkyl, a 4- to 6-membered monocyclic heterocyclyl, or a cubanyl, wherein each of the bridged bicyclic cycloalkyl, bridged bicyclic heterocyclyl, 4- to 6-membered monocyclic cycloalkyl, 4- to 6-membered monocyclic heterocyclyl, or cubanyl has from 1 to 4 R X and when the 4- to 6-membered monocyclic heterocyclyl or bridged bicyclic heterocyclyl contains a substitutable nitrogen moiety, the substitutable nitrogen is optionally substituted by R N1 may be optionally replaced by U is -NR 1 C(O)-, -C(O)NR 1 - or 5- to 6-membered heteroaryl; E is absent, a bond, or -NR 2 C(O)-, -C(O)NR 2 -, 5- to 6-membered heteroaryl, or 5- to 6-membered heterocyclyl, where the 5- to 6-membered heteroaryl or 5- to 6-membered heterocyclyl has 1 to 5 R G and when the 5- to 6-membered heteroaryl or 5- to 6-membered heterocyclyl contains a substitutable nitrogen moiety, the substitutable nitrogen is optionally substituted by R N2 or E is, and Y is a 4- to 9-membered nitrogen-containing monocyclic, bridged bicyclic, fused bicyclic, or spirocyclic heterocyclyl, wherein the 4- to 9-membered nitrogen-containing monocyclic, bridged bicyclic, fused bicyclic, or spirocyclic heterocyclyl has 1 to 5 R G and when a 4- to 9-membered nitrogen-containing monocyclic, bridged bicyclic, fused bicyclic, or spirocyclic heterocyclyl contains a substitutable nitrogen moiety, the substitutable nitrogen is optionally substituted by R N2 may be optionally replaced by L 1 is a bond, C 1 ~C 6 Alkylene, 2- to 7-membered heteroalkylene, -NR N3 - or -O-, where C 1 ~C 6 The alkylene or 2- to 7-membered heteroalkylene is 1 to 5 R L1 may be substituted by L 2 is absent or a bond, C 1 ~C 6 alkylene, 2- to 7-membered heteroalkylene, or -O-, where C 1 ~C 6 The alkylene or 2- to 7-membered heteroalkylene is 1 to 5 R L2 may be substituted by Here, E and L 2 Both cannot be a bond and not exist at the same time. R 1 is hydrogen or C 1 ~C 6 is alkyl, R 2 is hydrogen or C 1 ~C 6 is alkyl, W is an 8- to 10-membered partially unsaturated fused bicyclic ring moiety comprising a 5- to 6-membered heterocyclyl fused to a phenyl or a 5- to 6-membered heteroaryl, where the heterocyclyl has 1 to 4 R W1 and the phenyl or heteroaryl may be optionally substituted by 1 to 4 R at one or more available unsaturated carbons. W2 and when the heterocyclyl contains a substitutable nitrogen moiety, the substitutable nitrogen is optionally substituted by R N4 and where W is bonded to L through an available saturated carbon or nitrogen atom in the heterocyclyl. 2 Binds to A is C 3 ~C 6 cycloalkyl, phenyl, 4- to 6-membered heterocyclyl, 5- to 6-membered heteroaryl, or 8- to 10-membered bicyclic heteroaryl, where C 3 ~C 6 Cycloalkyl, phenyl, 4- to 6-membered heterocyclyl, 5- to 6-membered heteroaryl, or 8- to 10-membered bicyclic heteroaryl may have 1 to 5 R Y and when the 5- to 6-membered heteroaryl or 8- to 10-membered bicyclic heteroaryl contains a substitutable nitrogen moiety, the substitutable nitrogen is optionally substituted by R N5 may be optionally replaced by Each R L1 are independently hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkyl, Amino-C 1 ~C 6 Alkyl, cyano-C 1 ~C 6 Alkyl, oxo, halo, cyano, -OR A , -NR B R C , -NR B C(O)R D , -C(O)NR B R C , -C(O)R D , -C(O)OH, -C(O)OR D , -SR E , -S(O)R D , and -S(O) 2 R D is selected from the group consisting of Each R L2 are independently hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkyl, Amino-C 1 ~C 6 Alkyl, cyano-C 1 ~C 6 Alkyl, oxo, thioxo, halo, cyano, -OR A , -NR B R C , -NR B C(O)R D , -C(O)NR B R C , -C(O)R D , -C(O)OH, -C(O)OR D , -SR E , -S(O)R D , and -S(O) 2 R D is selected from the group consisting of R N1 is hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 2 ~C 6 Alkyl, halo-C 2 ~C 6 Alkyl, Amino-C 2 ~C 6 Alkyl, cyano-C 2 ~C 6 Alkyl, —C(O)NR B R C , -C(O)R D , -C(O)OR D , and -S(O) 2 R D is selected from the group consisting of R N2 is hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 2 ~C 6 Alkyl, halo-C 2 ~C 6 Alkyl, Amino-C 2 ~C 6 Alkyl, cyano-C 2 ~C 6 Alkyl, —C(O)NR B R C , -C(O)R D , -C(O)OR D , and -S(O) 2 R D is selected from the group consisting of R N3 is hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 2 ~C 6 Alkyl, halo-C 2 ~C 6 Alkyl, Amino-C 2 ~C 6 Alkyl, cyano-C 2 ~C 6 Alkyl, —C(O)NR B R C , -C(O)R D , -C(O)OR D , and -S(O) 2 R D is selected from the group consisting of R N4 is hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 2 ~C 6 Alkyl, C 1 ~C 6 Alkyl-C 1 ~C 6 Cycloalkyl, C 1 ~C 6 Alkenyl, —C(O)—C 1 ~C 6 Alkyl, —C(O)—C 1 ~C 6 Cycloalkyl, C 1 ~C 6 Alkyl-CO 2 H.C. 1 ~C 6 Alkyl-CO 2 -C 1 ~C 6 Alkyl, —C(O)—C 1 ~C 3 Alkyl-O-C 1 ~C 3 Alkyl-O-C 1 ~C 3 Alkyl, -C(O)-phenyl, -C(O)-heteroaryl, -C(O)-heterocyclyl, -S(O) 2 -C 1 ~C 6 Alkyl, -S(O) 2 -phenyl, -S(O) 2 -heteroaryl, -C(O)NR B R C and -C(O)OR D wherein: C 1 ~C 6 Alkyl, Hydroxy-C 2 ~C 6 Alkyl, C 1 ~C 6 Alkyl-C 1 ~C 6 Cycloalkyl, C 1 ~C 6 Alkenyl, C(O)-C 1 ~C 6 Alkyl, —C(O)—C 1 ~C 6 Cycloalkyl, C 1 ~C 6 Alkyl-CO 2 H.C. 1 ~C 6 Alkyl-CO 2 -C 1 ~C 6 Alkyl, -C(O)-heterocyclyl, and -S(O) 2 -C 1 ~C 6 The alkyl may be optionally substituted with one or more substituents, each of which may be independently fluoro, hydroxyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Alkyl (optionally substituted by 1, 2, or 3 fluorine atoms), and S(O) w C 1~6 alkyl (wherein w is 0, 1, or 2); and -C(O)-phenyl, -C(O)-heteroaryl, -S(O) 2 -phenyl, and -S(O) 2 Heteroaryl can be optionally substituted with one or more substituents, each of which is independently selected from halogen, hydroxyl, C 1 ~C 6 alkyl (optionally substituted by 1, 2 or 3 fluorine atoms), C 1 ~C 6 Alkoxy (optionally substituted by 1, 2 or 3 fluorine atoms), and S(O) 2 -NR B R C is selected from the group consisting of R N5 is hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 2 ~C 6 Alkyl, halo-C 2 ~C 6 Alkyl, Amino-C 2 ~C 6 Alkyl, cyano-C 2 ~C 6 Alkyl, —C(O)NR B R C , -C(O)R D , -C(O)OR D , and -S(O) 2 R D is selected from the group consisting of Each R W1 are independently hydrogen, C 1 ~C 6 Alkyl (-CO 2 H), hydroxy-C 1 ~C 6 Alkyl, Hydroxy-C 2 ~C 6 Alkyl-O-, halo-C 1 ~C 6 Alkyl, Amino-C 1 ~C 6 Alkyl, cyano-C 1 ~C 6 Alkyl, oxo, C=N-OH, halo, cyano, -OR A , -NR B R C , -NR B R CC , -NR B C(O)R D , -C(O)NR B R C , -C(O)R D , -C(O)OH, -C(O)OR D , -SR E , -S(O)R D , and -S(O) 2 R D is selected from the group consisting of Each R W2 are independently hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 1 ~C 6 Alkyl, Hydroxy-C 2 ~C 6 Alkyl-O-, halo-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkoxy, amino-C 1 ~C 6 Alkyl, cyano-C 1 ~C 6 Alkyl, halo, cyano, -OR A , -NR B R C , -NR B C(O)R D , -C(O)NR B R C , -C(O)R D , -C(O)OH, -C(O)OR D , -S(R F ) m , -S(O)R D , and -S(O) 2 R D or Two R on adjacent atoms W2 The groups, together with the atoms to which they are attached, form a 3- to 7-membered fused cycloalkyl, a 3- to 7-membered fused heterocyclyl, a fused aryl, or a 5- to 6-membered fused heteroaryl, each of which is represented by 1 to 5 R X may be substituted by Each R X are independently hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkoxy-C 1 ~C 6 Alkylene, Amino-C 1 ~C 6 Alkyl, cyano-C 1 ~C 6 Alkyl, oxo, halo, cyano, -OR A , -NR B R C , -NR B C(O)R D , -C(O)NR B R C , -C(O)R D , -C(O)OH, -C(O)OR D , -SR E , -S(O)R D , and -S(O) 2 R D is selected from the group consisting of Each R Y are independently hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkoxy, halo-C 1 ~C 6 Alkoxy-C 1 ~C 6 Alkylene, Amino-C 1 ~C 6 Alkyl, cyano-C 1 ~C 6 Alkyl, halo, cyano, oxo, -C 1 ~C 6 Alkylene-OR A , -OR A , -NR B R C , -NR B R CC , -NR B C(O)R D , -C(O)NR B R C , -C(O)R D , -C(O)OH, -C(O)OR D , -S(R F ) m , -S(O)R D , -S(O) 2 R D , and G 1 or Two R on adjacent atoms Y The groups, together with the atoms to which they are attached, form a 3- to 7-membered fused cycloalkyl, a 3- to 7-membered fused heterocyclyl, a fused aryl, or a 5- to 6-membered fused heteroaryl, each of which is represented by 1 to 5 R X may be substituted by Each G 1 is independently 3- to 7-membered cycloalkyl, 3- to 7-membered heterocyclyl, aryl, or 5- to 6-membered heteroaryl, where each of the 3- to 7-membered cycloalkyl, 3- to 7-membered heterocyclyl, aryl, or 5- to 6-membered heteroaryl is selected from 1 to 3 R Z may be substituted by Each R Z is independently 1 ~C 6 Alkyl, Hydroxy-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkyl, halo, cyano, -OR A , -NR B R C , -NR B C(O)R D , -C(O)NR B R C , -C(O)R D , -C(O)OH, -C(O)OR D , and -S(O) 2 R D is selected from the group consisting of R A is, in each occurrence, independently hydrogen, C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkoxy-C 1 ~C 6 Alkylene, C 1 ~C 6 Alkoxy-C 1 ~C 6 Alkylene, -C(O)NR B R C , -C(O)R D or -C(O)OR D and R B and R C Each of is independently hydrogen or C 1 ~C 6 is alkyl, or R B and R C together with the atoms to which they are attached, 1 to 3 R Z forming a 3- to 7-membered heterocyclyl ring optionally substituted by Each R CC is independently hydroxy-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkoxy-C 1 ~C 6 Alkylene, C 1 ~C 6 Alkyl-CO 2 H.C. 1 ~C 6 Alkyl-CO 2 -C 1 ~C 6 Alkyl, C(O)C 1 ~C 6 Alkyl, S(O) 2 -C 1 ~C 6 and 3- to 6-membered cycloalkyl and 4- to 6-membered heterocyclyl, wherein the 3- to 6-membered cycloalkyl and 4- to 6-membered heterocyclyl may be optionally substituted by one or more substituents, each of which is independently selected from the group consisting of C 1 ~C 6 Alkyl, Hydroxy-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 selected from the group consisting of alkyl, hydroxyl, halo, and -C(O)OH; Each R D is independently 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkyl, or halo-C 1 ~C 6 Alkoxy-C 1 ~C 6 is alkylene, Each R E are independently hydrogen, C 1 ~C 6 Alkyl or halo-C 1 ~C 6 is alkyl, Each R F are independently hydrogen, C 1 ~C 6 alkyl, or halo; Each R G are independently hydrogen, C 1 ~C 6 alkyl, halo, or oxo; and m is R F is hydrogen or C 1 ~C 6 1 for alkyl, and R F C 1 ~C 6 3 when alkyl, or R F is 5 for halo, A compound or a pharma- ceutically acceptable salt thereof.
2. D.
2. The compound of claim 1 selected from the group consisting of:
3. D.
3. The compound of claim 2 selected from the group consisting of:
4. U is *-NHC(O)-, *-C(O)NH-, and 2. The compound of claim 1, wherein the compound is selected from the group consisting of:
5. L 1 is a bond or C 1 ~C 6 alkylene, where C 1 ~C 6 Alkylene is 0 to 5 R L1 2. The compound of claim 1 , substituted by:
6. W is represented by the formula (W-a): wherein: X is O, NR N4 , or C(R X1 ) (R X2 ) and R N4 is hydrogen or C 1 ~C 6 is alkyl, R X1 is hydrogen or hydroxyl, R X2 is hydrogen or hydroxyl, or R X1 and R X2 together form an oxo moiety, The compound of claim 1.
7. W, is selected from the group consisting of Optionally, each R W2 is independently bromo, chloro, fluoro, or --CF 3 ; The compound according to claim 6.
8. The compound of claim 1 , wherein E is absent.
9. E is a bond, *-NR 2 C(O)-, *-C(O)NR 2 -, is selected from the group consisting of Optionally, R 2 is hydrogen; The compound of claim 1.
10. L 2 is a bond, -O-, C 1 ~C 6 alkylene, or 2- to 7-membered heteroalkylene, where C 1 ~C 6 Alkylene or 2- to 7-membered heteroalkylene is 1 to 5 R L2 and each R L2 are independently hydrogen, C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkyl, oxo, thioxo, halo, -OR A 2. The compound of claim 1 selected from the group consisting of:
11. L 2 is a bond, -CH 2 --, --CH 2 O-*, -C(O)-, -C(S)-, -OCH 2 C(O)-*, -C(O)NH-*, -OCH 2 -*, -OCH 2 11. The compound of claim 10, which is C(O)NH-*, or -O-, where "*" represents the point of attachment to A.
12. L 2 The compound of claim 1 , wherein
13. A, is selected from the group consisting of Optionally, R X is -CH 2 CH 2 OCF 3 and each R N5 is independently -C(O)CH 3 , -CF 3 , or -CH 2 CF 3 ; The compound of claim 1.
14. Each R Y are independently hydrogen, chloro, fluoro, hydroxyl, phenyl, oxo, -CHF 2 , -CF 3 , -CH 3 , -CH 2 CH 3 , -CH(CH 3 ) 2 , -OCH 3 , -OCHF 2 , -OCF 3 , -OCH 2 CF 3 , -OCH(CH 3 ) 2 , -CH 2 O.C.F. 3 , -CH 2 OCH 2 CF 3 , -CH 2 OCH 3 , -CH 2 CH 2 CH 2 O.C.F. 3 , -CH 2 CH 2 CH 2 CH 2 O.C.F. 3 , -CN, -OCH 2 CH 3 , -OCH 2 CH 2 CH 2 CF 3 , -OCH 2 CH 2 CH 2 C (CH 3 ) F 2 , -CH 2 CHF 2 , -CH 2 CF 3 , -CH 2 CH 2 CH 2 CF 3 , -NHCH 2 CH 2 O.C.F. 3 , -NHCH 2 CH 2 CH 2 O.C.F. 3 , -N(CH 3 ) CH 2 CH 2 O.C.F. 3 , -N(CH 3 ) CH 2 CH 2 CH 2 O.C.F. 3 , -N(CH 3 )CH(CH 3 ) CH 2 O.C.F. 3 , -OCH 2 CH 2 O.C.F. 3 , -OCH 2 CH 2 O.C.F. 2 , -OCH 2 CH 2 OCH 3 , -OCH 2 CH 2 CH 2 O.C.F. 3 , -OCH 2 CH 2 OCH 2 CF 3 , -OCH(CH 3 ) CH 2 O.C.F. 3 , -OCH 2 CH (CH 3 ) O.C.F. 3 , -CH 2 OCH 2 CH 2 O.C.F. 3 , -C(O)CH 2 O.C.F. 3 , -CH 2 O.C.(O)O.C.H. 2 CH 3 2. The compound of claim 1, wherein the aryl group is selected from the group consisting of cyclopropyl, cyclopropyl, and cyclopropyl.
15. R Y But, -C 1 ~C 6 Alkylene-OR A , -OR A or -NR B R CC 2. The compound of claim 1,
16. R Y is —O—C, which may be substituted with 1 to 6 halogens; 1 ~C 6 Alkylene-C 1 ~C 6 The compound of claim 1 which is alkoxy.
17. The compound of claim 1, wherein the compound has formula (I-b): or a pharma- ceutically acceptable salt thereof, In the formula, D is selected from the group consisting of: Each R 1 , R W2 , R X , and R A is as defined in formula (I); The compound according to any one of claims 1, 2, 4 to 7, and 9 to 16.
18. D is 18. The compound of claim 17, 19. The compound of claim 1, wherein the compound has formula (I-c): or a pharma- ceutically acceptable salt thereof, In the formula, D is selected from the group consisting of: E is a 5- to 6-membered heteroaryl, or a 5- to 6-membered heterocyclyl, where the 5- to 6-membered heteroaryl or the 5- to 6-membered heterocyclyl is optionally substituted at one or more available carbons with 1-5 R G , and if the 5- to 6-membered heteroaryl or the 5- to 6-membered heterocyclyl contains a substitutable nitrogen moiety, the substitutable nitrogen can be optionally substituted with R N2 ; Each R 1 , A, R N2 , R W2 , and R G is as defined in formula (I); The compound according to any one of claims 1, 2, 4 to 7, and 9 to 16.
20. Formula (II): or a pharma- ceutically acceptable salt thereof, During the ceremony, D II is a bridged bicyclic cycloalkyl, a bridged bicyclic heterocyclyl, a 4- to 6-membered monocyclic cycloalkyl, a 4- to 6-membered monocyclic heterocyclyl, or a cubanyl, wherein each of the bridged bicyclic cycloalkyl, bridged bicyclic heterocyclyl, 4- to 6-membered monocyclic cycloalkyl, 4- to 6-membered monocyclic heterocyclyl, or cubanyl has from 1 to 4 R X-II and when the 4- to 6-membered monocyclic heterocyclyl or bridged bicyclic heterocyclyl contains a substitutable nitrogen moiety, the substitutable nitrogen is optionally substituted by R N1-II may be optionally replaced by U II is -NR 1-II C(O)- or -C(O)NR 1-II - and E II is absent, a bond, -NR 2-II C(O)-, -C(O)NR 2-II -, 5- to 6-membered heteroaryl, or 5- to 6-membered heterocyclyl, where the 5- to 6-membered heteroaryl or 5- to 6-membered heterocyclyl has 1 to 5 R G-II and when the 5- to 6-membered heteroaryl or 5- to 6-membered heterocyclyl contains a substitutable nitrogen moiety, the substitutable nitrogen is optionally substituted by R N2-II or E II teeth, And Y II is a 4- to 9-membered nitrogen-containing monocyclic, bridged bicyclic, fused bicyclic, or spirocyclic heterocyclyl, wherein the 4- to 9-membered monocyclic, bridged bicyclic, fused bicyclic, or spirocyclic heterocyclyl has 1 to 5 R G-II and when a 4- to 9-membered nitrogen-containing monocyclic, bridged bicyclic, fused bicyclic, or spirocyclic heterocyclyl contains a substitutable nitrogen moiety, the substitutable nitrogen is optionally substituted by R N2-II may be optionally replaced by L 1-II is a bond, C 1 ~C 6 Alkylene, 2- to 7-membered heteroalkylene, -NR N3-II - or -O-, where C 1 ~C 6 The alkylene or 2- to 7-membered heteroalkylene is 1 to 5 R L1-II may be substituted by L 2-II is absent or a bond, C 1 ~C 6 alkylene, 2- to 7-membered heteroalkylene, —C(O)—, or —O—, where 1 ~C 6 The alkylene or 2- to 7-membered heteroalkylene is 1 to 5 R L2-II may be substituted by Here, E II and L 2-II Both cannot be a bond and not exist at the same time. R 1-II is hydrogen or C 1 ~C 6 is alkyl, R 2-II is hydrogen or C 1 ~C 6 is alkyl, W II is phenyl or 5- to 6-membered heteroaryl, where the phenyl or 5- to 6-membered heteroaryl is selected from 1 to 5 R W-II and when the 5- to 6-membered heteroaryl contains a substitutable nitrogen moiety, the substitutable nitrogen can be substituted by R N4-II may be optionally replaced by A II is C 3 ~C 6 cycloalkyl, 4- to 6-membered heterocyclyl, phenyl, or 5- to 6-membered heteroaryl, where C 3 ~C 6 Cycloalkyl, phenyl, or 5- to 6-membered heteroaryl may have 1 to 5 R Y-II and when the 5- to 6-membered heteroaryl contains a substitutable nitrogen moiety, the substitutable nitrogen can be substituted by R N5-II may be optionally replaced by Each R L1-II are independently hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkyl, Amino-C 1 ~C 6 Alkyl, cyano-C 1 ~C 6 Alkyl, oxo, halo, cyano, -OR A-II , -NR B-II R C-II , -NR B-II C(O)R D-II , -C(O)NR B-II R C-II , -C(O)R D-II , -C(O)OH, -C(O)OR D-II , -SR E-II , -S(O)R D-II , and -S(O) 2 R D-II is selected from the group consisting of Each R L2-II are independently hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkyl, Amino-C 1 ~C 6 Alkyl, cyano-C 1 ~C 6 Alkyl, oxo, halo, cyano, -OR A-II , -NR B-II R C-II , -NR B-II C(O)R D-II , -C(O)NR B-II R C-II , -C(O)R D-II , -C(O)OH, -C(O)OR D-II , -SR E-II , -S(O)R D-II , and -S(O) 2 R D-II is selected from the group consisting of R N1-II is hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 2 ~C 6 Alkyl, halo-C 2 ~C 6 Alkyl, Amino-C 2 ~C 6 Alkyl, cyano-C 2 ~C 6 Alkyl, —C(O)NR B-II R C-II , -C(O)R D-II , -C(O)OR D-II , and -S(O) 2 R D-II is selected from the group consisting of R N2-II is hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 2 ~C 6 Alkyl, halo-C 2 ~C 6 Alkyl, Amino-C 2 ~C 6 Alkyl, cyano-C 2 ~C 6 Alkyl, —C(O)NR B-II R C-II , -C(O)R D-II , -C(O)OR D-II , and -S(O) 2 R D-II is selected from the group consisting of R N3-II is hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 2 ~C 6 Alkyl, halo-C 2 ~C 6 Alkyl, Amino-C 2 ~C 6 Alkyl, cyano-C 2 ~C 6 Alkyl, —C(O)NR B-II R C-II , -C(O)R D-II , -C(O)OR D-II , and -S(O) 2 R D-II is selected from the group consisting of R N4-II is hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 2 ~C 6 Alkyl, C 1 ~C 6 Alkyl-C 1 ~C 6 Cycloalkyl, C 1 ~C 6 Alkenyl, —C(O)—C 1 ~C 6 Alkyl, —C(O)—C 1 ~C 6 Cycloalkyl, C 1 ~C 6 Alkyl-CO 2 H.C. 1 ~C 6 Alkyl-CO 2 -C 1 ~C 6 Alkyl, —C(O)—C 1 ~C3 alkyl-O-C 1 ~C 3 Alkyl-O-C 1 ~C 3 Alkyl, -C(O)-phenyl, -C(O)-heteroaryl, -C(O)-heterocyclyl, -S(O) 2 -C 1 ~C 6 Alkyl, -S(O) 2 -phenyl, -S(O) 2 -heteroaryl, -C(O)NR B-II R C-II and -C(O)OR D-II wherein: C 1 ~C 6 Alkyl, Hydroxy-C 2 ~C 6 Alkyl, C 1 ~C 6 Alkyl-C 1 ~C 6 Cycloalkyl, C 1 ~C 6 Alkenyl, C(O)-C 1 ~C 6 Alkyl, —C(O)—C 1 ~C 6 Cycloalkyl, C 1 ~C 6 Alkyl-CO 2 H.C. 1 ~C 6 Alkyl-CO 2 -C 1 ~C 6 Alkyl, -C(O)-heterocyclyl, and -S(O) 2 -C 1 ~C 6 The alkyl may be optionally substituted with one or more substituents, each of which may be independently fluoro, hydroxyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Alkyl (optionally substituted by 1, 2, or 3 fluorine atoms), and S(O) w-II C 1~6 alkyl (wherein w-II is 0, 1, or 2); and -C(O)-phenyl, -C(O)-heteroaryl, -S(O) 2 -phenyl, and -S(O) 2 Heteroaryl can be optionally substituted with one or more substituents, each of which is independently selected from halogen, hydroxyl, C 1 ~C 6 alkyl (optionally substituted by 1, 2 or 3 fluorine atoms), C 1 ~C 6 Alkoxy (optionally substituted by 1, 2 or 3 fluorine atoms), and S(O 2 ) N.R. B-II R C-II is selected from the group consisting of R N5-II is hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 2 ~C 6 Alkyl, halo-C 2 ~C 6 Alkyl, Amino-C 2 ~C 6 Alkyl, cyano-C 2 ~C 6 Alkyl, —C(O)NR B-II R C-II , -C(O)R D-II , -C(O)OR D-II , and -S(O) 2 R D-II is selected from the group consisting of Each R W-II are independently hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 1 ~C 6 Alkyl, Hydroxy-C 2 ~C 6 Alkyl-O-, halo-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkoxy, amino-C 1 ~C 6 Alkyl, cyano-C 1 ~C 6 Alkyl, oxo, C=N-OH, halo, cyano, -OR A-II , -NR B-II R C-II , -NR B-II R CC-II , -NR B-II C(O)R D-II , -C(O)NR B-II R C-II , -C(O)R D-II , -C(O)OH, -C(O)OR D-II , -SR E-II , -S(O)R D-II , and -S(O) 2 R D-II or Two R on adjacent atoms W-II The groups, together with the atoms to which they are attached, form a 3- to 7-membered fused cycloalkyl, a 3- to 7-membered fused heterocyclyl, a fused aryl, or a 5- to 6-membered fused heteroaryl, each of which is represented by 1 to 5 R X-II may be substituted by Each R X-II are independently hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkyl, Amino-C 1 ~C 6 Alkyl, cyano-C 1 ~C 6 Alkyl, oxo, halo, cyano, -OR A-II , -NR B-II R C-II , -NR B-II C(O)R D-II , -C(O)NR B-II R C-II , -C(O)R D-II , -C(O)OH, -C(O)OR D-II , -SR E-II , -S(O)R D-II , and -S(O) 2 R D-II is selected from the group consisting of Each R Y-II are independently hydrogen, C 1 ~C 6 Alkyl, Hydroxy-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkoxy, halo-C 1 ~C 6 Alkoxy-C 1 ~C 6 Alkylene, Amino-C 1 ~C 6 Alkyl, cyano-C 1 ~C 6 Alkyl, halo, cyano, -OR A-II , -NR B-II R C-II , -NR B-II C(O)R D-II , -C(O)NR B-II R C-II , -C(O)R D-II , -C(O)OH, -C(O)OR D-II , -S(R F-II ) m-II , -S(O)R D-II , -S(O) 2 R D-II , and G 1-II or Two R on adjacent atoms Y-II The groups, together with the atoms to which they are attached, form a 3- to 7-membered fused cycloalkyl, a 3- to 7-membered fused heterocyclyl, a fused aryl, or a 5- to 6-membered fused heteroaryl, each of which is represented by 1 to 5 R X-II may be substituted by Each G 1-II is independently 3- to 7-membered cycloalkyl, 3- to 7-membered heterocyclyl, aryl, or 5- to 6-membered heteroaryl, where each of the 3- to 7-membered cycloalkyl, 3- to 7-membered heterocyclyl, aryl, or 5- to 6-membered heteroaryl is selected from 1 to 3 R Z-II may be substituted by Each R Z-II is independently 1 ~C 6 Alkyl, Hydroxy-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkyl, halo, cyano, -OR A-II , -NR B-II R C-II , -NR B-II C(O)R D-II , -C(O)NR B-II R C-II , -C(O)R D-II , -C(O)OH, -C(O)OR D-II , and -S(O) 2 R D-II is selected from the group consisting of R A-II is, in each occurrence, independently hydrogen, C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkoxy-C 1 ~C 6 Alkylene, -C(O)NR B-II R C-II , -C(O)R D-II or -C(O)OR D-II and R B-II and R C-II Each of is independently hydrogen or C 1 ~C 6 is alkyl, or R B-II and R C-II together with the atoms to which they are attached, 1 to 3 R Z-II forming a 3- to 7-membered heterocyclyl ring optionally substituted by Each R CC-II is independently hydroxy-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 Alkyl, C 1 ~C 6 Alkyl-CO 2 H.C. 1 ~C 6 Alkyl-CO 2 -C 1 ~C 6 Alkyl, C(O)C 1 ~C 6 Alkyl, S(O) 2 -C 1 ~C 6 and 3- to 6-membered cycloalkyl and 4- to 6-membered heterocyclyl, wherein the 3- to 6-membered cycloalkyl and 4- to 6-membered heterocyclyl may be optionally substituted by one or more substituents, each of which is independently selected from the group consisting of C 1 ~C 6 Alkyl, Hydroxy-C 1 ~C 6 Alkyl, halo-C 1 ~C 6 selected from the group consisting of alkyl, hydroxyl, halo, and -C(O)OH; Each R D-II is independently 1 ~C 6 Alkyl or halo-C 1 ~C 6 is alkyl, Each R E-II are independently hydrogen, C 1 ~C 6 Alkyl or halo-C 1 ~C 6 is alkyl, Each R F-II are independently hydrogen, C 1 ~C 6 alkyl, or halo; and Each R G-II are independently hydrogen, C 1 ~C 6 alkyl, halo, or oxo; However, D II When is a bridged bicyclic 5-membered cycloalkyl, E II is -NR 2-II C(O)-; A compound or a pharma- ceutically acceptable salt thereof.
21. below: and pharma- ceutically acceptable salts thereof.
